Increased E‐cadherin tumour levels.Increased levels of apoptosis.Decreased vimentin, N‐cadherin, tumour volume, and tumour weight.Decreased tumour levels of oncoprotein E6 and E7. This evidence concerns the gene CDH1 and neoplasm.